<DOC>
	<DOCNO>NCT01748864</DOCNO>
	<brief_summary>A Phase 1 , single-center , open-label , single arm , baseline-controlled ( safety ) study normal volunteer . Study determine biodistribution excretion radioactive drug substance evaluate safety tolerability 99mTC-Etarfolatide normal volunteer .</brief_summary>
	<brief_title>Evaluation Biodistribution Safety 99mTC-Etarfolatide ( EC20 ) Normal Volunteers</brief_title>
	<detailed_description />
	<criteria>Subject must 18 year age old . Subject must major health problem deem principal investigator . Subject must provide informed consent prior enrollment . Subject pregnant breastfeeding . Subject simultaneously participate another investigative drug device study . Subject must complete followup phase previous study least 30 day prior enrollment study . Subject known history chronic abuse drug alcohol test positive prestudy urine drug abuse screen . Subject currently take folic acid supplement stop take supplement period 8 day ( 7 day prior study one day last imaging procedure ) . Subject 's physical condition unsuitable radionuclide imaging . Subject administer another radiopharmaceutical would interfere assessment biodistribution 99mTcetarfolatide .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Volunteers</keyword>
</DOC>